News for hackers. Stuff that matters.
Re:Multiple sclerosis has a common viral culprit, opening do... by refurb on Sunday August 14, 2022 @10:00PM (#32465062)
Rituximab was shown to be inferior in a head to head comparison against ocrelizumab.

There are no comments on this comment yet.